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Abstract Tail-anchored proteins are post-translationally tar-
geted and inserted into the endoplasmic reticulum membrane.
They do not use the co-translational signal-recognition particle
(SRP)-dependent pathway, but rather utilize an ill-defined,
ATP-dependent mechanism. Here, we show that a tail-anchored
protein can be cleaved by signal peptidase and that the sequence
requirements for efficient cleavage seem to be the same as
for cleavage of co-translationally targeted SRP-dependent
proteins. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
Key words: Membrane protein; Signal peptide;
Signal peptidase; Tail-anchor
1. Introduction
The ‘tail-anchored’ proteins constitute an interesting sub-
class of the integral membrane proteins. These proteins do
not have an N-terminal signal sequence and are targeted
post-translationally to the endoplasmic reticulum (ER) mem-
brane by virtue of a C-terminal hydrophobic segment [1]. The
C-terminal tail downstream of the hydrophobic segment is
translocated across the ER membrane by an ill-de¢ned,
ATP-dependent process [2^6], leaving the bulk of the protein
facing the cytosol.
Previous work has shown that membrane integration of the
tail-anchored protein synaptobrevin (Syb) can be e¡ected by
poly-Leu segments of 12^18 residues in place of the wild-type
transmembrane domain [7]. Here we show that signal pepti-
dase, an enzyme complex that associates with and can be
crosslinked to the Sec61 translocon [8], can e⁄ciently cleave
Syb constructs with transmembrane segments composed of a
poly-Leu stretch followed by a canonical signal peptidase
cleavage cassette, but only if the poly-Leu stretch is shorter
than V16 residues. This maximal length is very similar to
what we have previously found for signal peptidase cleavage
of a poly-Leu signal sequence in a signal-recognition particle
(SRP)-dependent protein [9], strongly suggesting that proteins
utilizing the tail-anchored assembly pathway and those tar-
geted via the SRP pathway have access to the signal peptidase
in the same fashion.
2. Materials and methods
2.1. Enzymes and chemicals
Unless otherwise stated, all enzymes, plasmid pGEM3LG1, and
rabbit reticulocyte lysate were from Promega (Madison, WI, USA)
or New England Biolabs (Boston, MA, USA). T7 DNA polymerase,
[35S]Met, 14C-methylated marker proteins, ribonucleotides, deoxyribo-
nucleotides, dideoxyribonucleotides, and the cap analogs m7G(5P)-
ppp(5P)G were from Amersham-Pharmacia Biotech (Uppsala, Swe-
den, and Piscataway, NJ, USA). Dog pancreas rough microsomes
(RMs) were prepared as described in [10]. The competitive glycosyl-
ation inhibitor peptide benzoyl-Asn-Leu-Thr-methylamide was from
Quality Controlled Biochemicals (Hopkinton, MA, USA). The signal
peptidase inhibitor N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl
ketone was from Sigma Chemical (St. Louis, MO, USA).
2.2. DNA manipulations
Site-speci¢c mutagenesis was performed using the Quick Change
Site Directed Mutagenesis kit from Stratagene. All mutants were con-
¢rmed by sequencing of plasmid DNA. All cloning steps were done
according to standard procedures.
2.3. Expression plasmids
Syb2-Ln-CC constructs were made from the previously described
Syb2-17L-G13 construct and were cloned into the pGEM3LG1 plas-
mid behind the T7 promoter as a PstI^BamHI fragment as described
in [7]. The signal peptidase cleavage cassette was introduced by ligat-
ing double-stranded oligonucleotides between the SpeI and NdeI sites
in the Syb2-17L-G13 construct. The amino acid sequence TLVQQQ-
YVT at the C-terminal end of the 17L stretch was changed to TLV-
PSAQAsAYVT (the intended signal peptidase cleavage site is indi-
cated by the arrow) to make the Syb-L17-CC construct. The length of
the poly-Leu segment in Syb-L17-CC was changed by PCR mutagen-
esis to make the full series of Syb-Ln-CC constructs. To make Syb-
L15-CC(Q31), the signal peptidase cleavage cassette TLVPSAQA-
sAYVT was changed to TLVPSAQQsAYVT in Syb-L15-CC. A ver-
sion of Syb-L15-CC truncated after the intended signal peptidase
cleavage site was made by introducing two stop codons (TGA
TAG) immediately downstream of the TLVPSAQA sequence.
2.4. Expression in vitro
DNA template for in vitro transcription of full-length Syb mRNA
was prepared by transcription of the Syb-pGEM3LG1 plasmid with
T7 RNA polymerase for 1 h at 37‡C. The transcription mixture was
as follows: 1^5 Wg DNA template, 5 Wl 10U T7 bu¡er (400 mM Tris^
HCl, pH 7.9, 60 mM MgCl2), 5 Wl bovine serum albumin (1 Wg/Wl),
5 Wl m7G(5P)ppp(5P)G (10 mM), 5 Wl dithiothreitol (50 mM), 5 Wl
rNTP mix (10 mM ATP, 10 mM CTP, 10 mM UTP, 5 mM GTP),
18.5 Wl H2O, 1.5 Wl RNase inhibitor (40 U/Wl), and 2 Wl T7 RNA
polymerase (20 U/Wl) in a total volume of 50 Wl. Translation of 1 Wl
Syb mRNA in 9 Wl nuclease-treated reticulocyte lysate, 1 Wl RNase
inhibitor (40 U/Wl), 1 Wl [35S]Met (10 WCi/Wl), 1 Wl amino acids mix
(1 mM of each amino acid except Met), 1 Wl RM (four equivalents)
was performed as described in [11] at 30‡C for 1 h. After translation,
membranes were sedimented through a sucrose cushion in a Beckman
airfuge at 4‡C for 5 min at 20 psi, and the supernatant and pellet
fractions were separated.
For post-translational translocation of Syb-Ln-CC constructs, the
incubation was ¢rst performed without microsomes at 30‡C for 30 min.
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Microsomes were then added and the incubation was continued for
another 30 min. When relevant, apyrase was added to a ¢nal concen-
tration of 50 mU/Wl [12] and the translation mix was incubated at
30‡C for 10 min before the addition of microsomes.
Proteins were analyzed by SDS^PAGE and gels were visualized on
a Bio-Rad Molecular Imager FX using the Quantity One Quantita-
tion software.
3. Results
We have previously shown that the tail-anchored protein
Syb can be integrated into microsomal membranes when the
wild-type C-terminal hydrophobic segment is replaced by a
poly-Leu segment that is at least 12 residues long [7]. In an
attempt to study processing by signal peptidase of such Syb-
Ln constructs (where n denotes the number of consecutive Leu
residues), we engineered a canonical signal peptidase cleavage
cassette TLnVPSAQAsAYVT at the C-terminal end of the
poly-Leu stretch, Fig. 1. These Syb-Ln-CC constructs were
expressed in vitro in the presence of dog pancreas RM and
were analyzed by SDS^PAGE. An acceptor site for N-linked
glycosylation (underlined in Fig. 1) was included 21 residues
downstream of the hydrophobic segment to serve as a con-
venient marker for translocation of the C-terminal tail into
the lumen of the microsomes.
To demonstrate that the integration of the Syb-Ln-CC con-
structs into the membrane is post-translational and ATP-de-
pendent, the Syb-L18-CC construct was expressed with micro-
somes added post-translationally, Fig. 2A. Translocation of
the C-terminal tail was readily apparent from the glycosyla-
tion of the C-terminal acceptor site (lanes 1, 3); addition of
the competitive glycosylation peptide inhibitor benzoyl-Asn-
Leu-Thr-methylamide prevented modi¢cation of the C-tail
(lanes 5, 6). When apyrase was added together with the micro-
somes in order to deplete ATP from the reaction mixture, no
translocation was observed (lane 4). C-tail translocation was
somewhat more e⁄cient when RMs were present from the
start of the translation reaction (lane 2), presumably because
this minimizes aggregation of the Syb product. Similar results
were obtained with the two other constructs tested in this
way, Syb-L13-CC and Syb-L15-CC (data not shown).
As a comparison, the SRP-dependent protein leader pepti-
dase was translated under the same conditions, Fig. 2B. A
glycosylation site in the lumenal C-terminal domain served
as a convenient marker for proper translocation. As expected,
co- but not post-translational translocation was seen in this
case (compare lanes 2 and 3).
Having established that Syb-Ln-CC constructs were inserted
into the microsomes by the post-translational tail-anchored
pathway, we next expressed a series of constructs where the
length of the hydrophobic transmembrane segment was varied
from 18 down to 13 residues, Fig. 3A. The full-length, glyco-
sylated protein (G) was only seen for constructs with nv15,
whereas constructs with shorter hydrophobic segments gave
rise to products of lower molecular mass (C1, C2) than the
unglycosylated full-length protein (F). Only the G and C1
products were e⁄ciently pelleted in the membrane fraction
(lanes 7^12). As demonstrated in Fig. 3B, the main C1-prod-
Fig. 1. The Syb-Ln-CC series of constructs. The wild-type trans-
membrane segment has been replaced by a poly-Leu sequence end-
ing with a signal peptidase cleavage cassette (the intended cleavage
site is indicated by the arrow), and the C-terminal tail has been re-
placed by a stretch of polar amino acids including an acceptor site
for N-linked glycosylation (indicated by Y in the cartoon and
underlined in the amino acid sequence).
Fig. 2. Post-translational translocation of the Syb-L18-CC C-tail
across the microsomal membrane. A: Syb-L18-CC was translated in
the absence (lanes 1, 3^4) or presence (lanes 2, 5, 6) of RM. In
lanes 3 and 4, RMs were added post-translationally (after 30 min)
and incubation was continued for another 30 min; in lane 4 apyrase
was included to remove ATP from the reaction mixture. In lane 6,
the competitive glycosylation inhibitor benzoyl-Asn-Leu-Thr-methyl-
amide was included during translation. F: Full-length, unglycosy-
lated protein, G: full-length, glycosylated form. A background band
present both in the absence and presence of RMs is indicated by an
asterisk. B: The SRP-dependent protein leader peptidase (left) was
translated in the absence of RMs (lane 1), in the presence of RMs
(lane 2), and with RMs added post-translationally (lane 3). F: Full-
length, unglycosylated protein, G: full-length protein that has been
glycosylated on Asn214 (indicated by Y in the cartoon) in the large
C-terminal domain, cf. [14].
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uct in Syb-L15-CC co-migrated with a version of Syb-L15-CC
that was truncated at the intended signal peptidase cleavage
site (lanes 3, 4), and the formation of C1 was inhibited both
by a Ala31CGln mutation at the signal peptidase cleavage
site (lanes 1, 2) and by the signal peptidase inhibitor N-me-
thoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl ketone (lanes 7^
9; this inhibitor has been shown to inhibit microsomal signal
peptidase in vitro ^ M. Lively, personal communication). C1
therefore represents a Syb derivative that has been shortened
by signal peptidase-mediated cleavage of its lumenally ex-
posed C-terminal tail. The F product presumably represents
full-length proteins that have not been properly targeted to
the microsomes, cf. Fig. 2A. The C2 product may represent
molecules that have initially been inserted into the membrane
and then released into the supernatant after cleavage in or just
before the hydrophobic C-terminal segment. We have not yet
established the identity of the C2 fragment; it may result from
processing of the poly-Leu segment by the recently identi¢ed
signal peptide peptidase in the ER [13].
4. Discussion
We have analyzed a series of constructs derived from the
tail-anchored protein Syb. All constructs have a C-terminal
hydrophobic segment composed of one valine and between 13
and 18 leucines, followed by a canonical signal peptidase
cleavage cassette (Fig. 1). Just as observed for wild-type Syb
[2], these constructs can be inserted post-translationally into
microsomal membranes in vitro and their C-terminal tail can
be translocated into the microsomal lumen in an ATP-depen-
dent reaction (Fig. 2). Their mode of targeting and insertion
into the ER membrane is thus distinct from the co-transla-
tional SRP-dependent insertion pathway [1], yet, surprisingly,
we observe e⁄cient cleavage by signal peptidase of the shorter
constructs (Fig. 3).
Interestingly, the maximal length of the hydrophobic poly-
Leu stretch that allows e⁄cient cleavage is 16 residues (15 L
plus one V), which is close to the maximal length (16 L plus
one V) determined previously for signal peptidase cleavage of
poly-Leu signal-anchor sequences in a co-translationally tar-
geted protein [9]. Thus, although integrated into the micro-
somal membrane by distinctly di¡erent mechanisms, proteins
assembled through the co-translational SRP pathway and
proteins utilizing the post-translational tail-anchored pathway
both end up being accessible for cleavage by the signal pepti-
dase enzyme. Each polypeptide therefore must gain access to
and be recognized by the signal peptidase active site. Given
that the signal peptidase complex can be crosslinked to and is
thought to be associated with the Sec61 complex [8], this
means either that the active site in a translocon-bound signal
peptidase can be approached by a tail-anchored protein dif-
fusing in the membrane, that some signal peptidase complexes
are found free in the bilayer, or that tail-anchored proteins
also utilize the Sec61p translocon for membrane insertion
even though they are not targeted by SRP. The recent ¢nding
that a newly synthesized tail-anchored protein can be cross-
linked to components of the Sec61p translocon (S. High, per-
sonal communication) suggests that the last possibility may be
the most likely. More work will be required to provide de¢n-
itive evidence for this however.
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Fig. 3. The C-terminal tail in the Syb-Ln-CC constructs is removed
by signal peptidase when n916. A: The indicated constructs were
translated in the presence of RM. Total samples are shown in lanes
1^6 and the membrane pellets are shown in lanes 7^12. F: Full-
length, unglycosylated proteins, G: full-length, glycosylated proteins,
C1: proteins cleaved by signal peptidase (these are unglycosylated
since the glycosylation site is in the C-terminal tail, cf. Fig. 1), C2:
a second cleavage product of unknown origin. B: Syb-L15-CC(Q31)
(lanes 1, 2), Syb-L15-CC truncated at the intended signal peptidase
cleavage site (lanes 3, 4), and Syb-L15-CC (lanes 5^9) were trans-
lated in the absence (^) or presence (+) of RM either with no addi-
tions (lanes 1^7), with addition of the competitive glycosylation in-
hibitor peptide benzoyl-Asn-Leu-Thr-methylamide (lane 8), or with
the addition of the signal peptidase inhibitor N-methoxysuccinyl-
Ala-Ala-Pro-Val-chloromethyl ketone (lane 9). Total samples are
shown in lanes 1^6 and membrane pellet fractions are shown in
lanes 7^9.
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